New Migraine Drugs Offer Hope, But Access Hurdles Persist
Breakthrough treatments can significantly reduce debilitating migraine attacks, yet many patients face lengthy waits and bureaucratic obstacles to obtain them.
Breakthrough treatments can significantly reduce debilitating migraine attacks, yet many patients face lengthy waits and bureaucratic obstacles to obtain them.
Early research indicates GLP-1 medications like Ozempic and Wegovy could weaken the link between impulsivity and violent behavior.
Research suggests users of medications like Ozempic and Wegovy are exercising less, raising concerns about muscle mass preservation and long-term health.
Analysis of Euro 2024 data reveals fewer emergency room attendances during Three Lions' games, with experts advising continued use of health services.
Professor Kevin Mortimer, diagnosed at 48, is now cancer-free two years later, highlighting advancements in treatment and disparities in access.
New research suggests hundreds of thousands of adults may have ADHD without a diagnosis, with older adults being the most affected group.
A salon in Lowestoft, England, has become a destination for families seeking haircuts tailored to the needs of neurodivergent individuals.
A Cambridge mother battled a life-threatening infection that rapidly deteriorated her condition, requiring emergency surgery and a coma.
Robert F. Kennedy Jr. overruled federal medical review recommending release for a cruise ship passenger exposed to hantavirus.